HIKAL LTD - stock earnings
HIKAL.NS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 27, 2024 BeforeMarket | - / 1.0000000000 | - | - / 4.3 billion | - |
HIKAL.NS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 161.4 million INR | 4.5 billion INR |
| 2023Q3 | 125.7 million INR | 4.3 billion INR |
| 2023Q2 | 69.2 million INR | 3.9 billion INR |
| 2023Q1 | 359.9 million INR | 5.4 billion INR |
| 2022Q4 | 264.1 million INR | 5.4 billion INR |
| 2022Q3 | 248.4 million INR | 5.6 billion INR |
| 2022Q2 | -88.6 million INR | 3.7 billion INR |
| 2022Q1 | 207.0 million INR | 5.0 billion INR |
| 2021Q4 | 452.0 million INR | 5.1 billion INR |
| 2021Q3 | 440.6 million INR | 4.6 billion INR |
| 2021Q2 | 505.4 million INR | 4.5 billion INR |
| 2021Q1 | 509.1 million INR | 5.3 billion INR |
| 2020Q4 | 402.8 million INR | 4.6 billion INR |
| 2020Q3 | 269.5 million INR | 3.7 billion INR |
| 2020Q2 | 150.0 million INR | 3.5 billion INR |
| 2020Q1 | 244.8 million INR | 4.2 billion INR |
| 2019Q4 | 283.6 million INR | 3.9 billion INR |
| 2019Q3 | 63.7 million INR | 3.2 billion INR |
| 2019Q2 | 252.3 million INR | 4.0 billion INR |
| 2019Q1 | 333.3 million INR | 4.7 billion INR |
| 2018Q4 | 293.8 million INR | 4.1 billion INR |
| 2018Q3 | 244.3 million INR | 3.9 billion INR |
| 2018Q2 | 159.3 million INR | 3.3 billion INR |
| 2017Q4 | 232.4 million INR | 3.5 billion INR |
| 2016Q4 | 138.3 million INR | 2.6 billion INR |
| 2014Q1 | 28.8 million INR | 2.3 billion INR |
| 2013Q4 | 102.8 million INR | 2.2 billion INR |
| 2013Q1 | 90.1 million INR | 1.9 billion INR |
| 2012Q4 | 90.3 million INR | 1.5 billion INR |
| 2012Q3 | 21.2 million INR | 1.5 billion INR |
| 2012Q2 | 51.0 million INR | 1.7 billion INR |
HIKAL.NS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 783.8 million INR | 20.0 billion INR |
| 2022 | 1.6 billion INR | 19.3 billion INR |
| 2021 | 1.3 billion INR | 17.1 billion INR |
| 2020 | 844.4 million INR | 15.1 billion INR |
| 2019 | 1.0 billion INR | 15.9 billion INR |
| 2018 | 772.3 million INR | 13.0 billion INR |
| 2017 | 638.8 million INR | 10.0 billion INR |
| 2016 | 412.0 million INR | 9.1 billion INR |
| 2015 | 404.1 million INR | 8.6 billion INR |
| 2014 | 639.0 million INR | 8.3 billion INR |
| 2013 | 252.5 million INR | 6.6 billion INR |
| 2012 | 460.3 million INR | 7.1 billion INR |
| 2011 | 371.7 million INR | 5.0 billion INR |
| 2010 | 502.8 million INR | 5.4 billion INR |
| 2009 | 407.8 million INR | 5.7 billion INR |
| 2008 | 474.4 million INR | 4.8 billion INR |
| 2007 | 191.1 million INR | 4.4 billion INR |
HIKAL.NS
Price: ₹297.95
Dividend Yield: 0.42%
Forward Dividend Yield: 0.40%
Payout Ratio: 20.62%
Dividend Per Share: 1.20 INR
Earnings Per Share: 5.82 INR
P/E Ratio: 43.52
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 35.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 15
DGR3: -5.68%
DGR5: 11.07%
DGR10: 12.71%